Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06607289
What this trial is testing

National Longitudinal Cohort of Hematological Diseases (NICHE) - CART

Who this might be right for
Hematological Malignancies
Institute of Hematology & Blood Diseases Hospital, China 1,000
Not applicableLooking for participantsNCT07051525
What this trial is testing

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Who this might be right for
LeukemiaCART TherapyTransplantation, Stem Cell+1 more
Peter MacCallum Cancer Centre, Australia 214
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)UnknownNCT05286164
What this trial is testing

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

Who this might be right for
CART TreatmentB Cell Lymphoma
Tel-Aviv Sourasky Medical Center 30
Early research (Phase 1)Looking for participantsNCT06420089
What this trial is testing

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
T Cell Non-Hodgkin Lymphoma
Vittoria Biotherapeutics 30
Early research (Phase 1)Looking for participantsNCT07464951
What this trial is testing

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Stephan Grupp MD PhD 30
Not applicableStudy completedNCT04923789
What this trial is testing

ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 100
Not applicableUnknownNCT05308875
What this trial is testing

Efficacy and Safety Evaluation of PD1-BCMA-CART

Who this might be right for
Multiple Myeloma
Bioray Laboratories 9
Early research (Phase 1)Ended earlyNCT04227275
What this trial is testing

CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 16
Early research (Phase 1)UnknownNCT04008394
What this trial is testing

Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies

Who this might be right for
Adult T-Cell Lymphoma/LeukaemiaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)UnknownNCT03146533
What this trial is testing

CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.

Who this might be right for
B Cell Lymphoma
Shenzhen Second People's Hospital 20
Not applicableStudy completedNCT04723706
What this trial is testing

Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients

Who this might be right for
Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
Henry Ford Health System 33
Early research (Phase 1)Ended earlyNCT02465983
What this trial is testing

Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Pennsylvania 4
Not applicableLooking for participantsNCT05514327
What this trial is testing

Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaCAR-TRadiotherapy+1 more
Peking Union Medical College Hospital 20
Early research (Phase 1)Looking for participantsNCT06209619
What this trial is testing

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentDiffuse Large B-Cell Lymphoma-RecurrentFollicular Lymphoma-Recurrent+9 more
Nathan Denlinger 18
Early research (Phase 1)Active Not RecruitingNCT07209241
What this trial is testing

Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

Who this might be right for
Recurrent Glioblastoma
University of Pennsylvania 12
Early research (Phase 1)Looking for participantsNCT06185751
What this trial is testing

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT04351022
What this trial is testing

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)WithdrawnNCT04419909
What this trial is testing

Retreatment With CTL019/CTL119

Who this might be right for
Lymphoma, B-Cell
University of Pennsylvania
Testing effectiveness (Phase 2)Looking for participantsNCT06608342
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Next Page